Diker Charles M
Director at L; Chairman at CANTEL MEDICAL CORP
- Sold, on record
- $34.2M
- Dollars the filings state
- Form 4 sales
- 76
- Latest Dec 1, 2025
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- LLOEWS CORPDirector
- CANTEL MEDICAL CORPChairman
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CANTEL MEDICAL CORP589,473 shares
- L35,236 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LRoutineJun 3 2024
Sold 963 shares at $75.79 ($73k)
Diker Charles M, Director
10b5-1 planSold 4.6% of holdings ($1.6M position)19,906 shares left1.5x usual sizeFiling
- 2 Form 4 sale LRoutineSep 3 +92 days
Sold 1,088 shares at $81.37 ($89k)
Diker Charles M, Director
10b5-1 planSold 5.2% of holdings ($1.7M position)19,906 shares left1.6x usual sizeFiling
- 3 Form 144 notice LNoticeDec 2 +90 days
Filed to sell 1,146 shares ($100k)
Diker Charles M, Director
10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale LRoutineDec 2 same day
Sold 1,146 shares at $86.83 ($100k)
Diker Charles M, Director
10b5-1 planSold 5.4% of holdings ($1.8M position)19,906 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 4 sale LRoutineMar 3 +91 days
Sold 1,197 shares at $86.73 ($104k)
Diker Charles M, Director
10b5-1 planSold 5.7% of holdings ($1.8M position)19,906 shares left1.3x usual sizeFiling
- 6 Form 4 sale LRoutineJun 2 +91 days
Sold 1,274 shares at $88.37 ($113k)
Diker Charles M, Director
10b5-1 planSold 5.7% of holdings ($2M position)21,194 shares left1.3x usual sizeFiling
- 7 Form 4 sale LRoutineSep 2 +92 days
Sold 1,422 shares at $96.76 ($138k)
Diker Charles M, Director
10b5-1 planSold 6.2% of holdings ($2.2M position)21,343 shares left1.3x usual sizeFiling
- 8 Form 4 sale LRoutineDec 1 +90 days
Sold 1,442 shares at $107.93 ($156k)
Diker Charles M, Director
10b5-1 planSold 6.3% of holdings ($2.5M position)21,594 shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (80)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | L | Director | Form 4 sale | 1,442 | $156k | 6.3% | Routine | SEC |
| Sep 2, 2025 | L | Director | Form 4 sale | 1,422 | $138k | 6.2% | Routine | SEC |
| Jun 2, 2025 | L | Director | Form 4 sale | 1,274 | $113k | 5.7% | Routine | SEC |
| Mar 3, 2025 | L | Director | Form 4 sale | 1,197 | $104k | 5.7% | Routine | SEC |
| Dec 2, 2024 | L | Director | Form 4 sale | 1,146 | $100k | 5.4% | Routine | SEC |
| Dec 2, 2024 | L | Director | Form 144 notice | 1,146 | $100k | Notice | SEC | |
| Sep 3, 2024 | L | Director | Form 4 sale | 1,088 | $89k | 5.2% | Routine | SEC |
| Jun 3, 2024 | L | Director | Form 4 sale | 963 | $73k | 4.6% | Routine | SEC |
| Mar 1, 2024 | L | Director | Form 4 sale | 951 | $71k | 5.0% | Routine | SEC |
| Dec 1, 2023 | L | Director | Form 4 sale | 715 | $50k | 3.8% | Routine | SEC |
| Dec 1, 2023 | L | Director | Form 144 notice | 715 | $50k | Notice | SEC | |
| Sep 1, 2023 | L | Director | Form 4 sale | 561 | $35k | 3.0% | Routine | SEC |
| Sep 1, 2023 | L | Director | Form 144 notice | 561 | $35k | Notice | SEC | |
| Jun 1, 2023 | L | Director | Form 4 sale | 474 | $27k | 2.5% | Routine | SEC |
| Jun 1, 2023 | L | Director | Form 144 notice | 474 | $27k | Notice | SEC | |
| Mar 1, 2023 | L | Director | Form 4 sale | 625 | $38k | 3.6% | Plan not stated | SEC |
| Dec 1, 2022 | L | Director | Form 4 sale | 698 | $41k | 4.0% | Plan not stated | SEC |
| Sep 1, 2022 | L | Director | Form 4 sale | 572 | $31k | 3.3% | Plan not stated | SEC |
| Jun 1, 2022 | L | Director | Form 4 sale | 883 | $57k | 5.0% | Plan not stated | SEC |
| Mar 1, 2022 | L | Director | Form 4 sale | 797 | $48k | 5.1% | Plan not stated | SEC |
| Dec 1, 2021 | L | Director | Form 4 sale | 459 | $25k | 3.0% | Plan not stated | SEC |
| Sep 1, 2021 | L | Director | Form 4 sale | 561 | $31k | 3.6% | Plan not stated | SEC |
| Jun 1, 2021 | L | Director | Form 4 sale | 429 | $25k | 2.8% | Plan not stated | SEC |
| Mar 1, 2021 | L | Director | Form 4 sale | 170 | $8k | 1.4% | Plan not stated | SEC |
| Dec 1, 2020 | L | Director | Form 4 sale | 139 | $6k | 1.2% | Plan not stated | SEC |
| Jun 1, 2020 | L | Director | Form 4 sale | 12 | $400 | 0.1% | Plan not stated | SEC |
| Mar 2, 2020 | L | Director | Form 4 sale | 322 | $15k | 3.2% | Plan not stated | SEC |
| Dec 2, 2019 | L | Director | Form 4 sale | 428 | $22k | 4.3% | Plan not stated | SEC |
| Oct 23, 2019 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 8,000 | $567k | 0.3% | Plan not stated | SEC |
| Sep 3, 2019 | L | Director | Form 4 sale | 411 | $20k | 4.1% | Plan not stated | SEC |
| Jun 3, 2019 | L | Director | Form 4 sale | 706 | $37k | 6.8% | Plan not stated | SEC |
| Mar 1, 2019 | L | Director | Form 4 sale | 820 | $39k | 9.6% | Unusual | SEC |
| Dec 3, 2018 | L | Director | Form 4 sale | 664 | $32k | 8.0% | Unusual | SEC |
| Sep 4, 2018 | L | Director | Form 4 sale | 357 | $18k | 4.4% | Unusual | SEC |
| Jun 1, 2018 | L | Director | Form 4 sale | 52 | $3k | 0.7% | Plan not stated | SEC |
| Mar 29, 2018 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 11,900 | $1.3M | 0.4% | Plan not stated | SEC |
| Mar 13, 2018 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 20,000 | $2.3M | 0.7% | Plan not stated | SEC |
| Mar 1, 2018 | L | Director | Form 4 sale | 274 | $14k | 4.7% | Plan not stated | SEC |
| Jan 16, 2018 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 10,000 | $1.1M | 0.3% | Plan not stated | SEC |
| Jan 11, 2018 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 9,978 | $1.1M | 0.3% | Plan not stated | SEC |
| Dec 27, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 18,000 | $1.8M | 0.6% | Plan not stated | SEC |
| Dec 19, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 12,000 | $1.2M | 0.4% | Plan not stated | SEC |
| Dec 1, 2017 | L | Director | Form 4 sale | 32 | $2k | 0.6% | Plan not stated | SEC |
| Oct 4, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 20,500 | $2M | 0.7% | Plan not stated | SEC |
| Jul 12, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 35,000 | $2.6M | 1.1% | Plan not stated | SEC |
| Jun 12, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 13,000 | $993k | 0.4% | Plan not stated | SEC |
| Mar 31, 2017 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 17,000 | $1.4M | 0.5% | Plan not stated | SEC |
| Mar 1, 2017 | L | Director | Form 4 sale | 58 | $3k | 1.9% | Plan not stated | SEC |
| Dec 1, 2016 | L | Director | Form 4 sale | 101 | $5k | 3.3% | Plan not stated | SEC |
| Oct 20, 2016 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 3,000 | $227k | 0.1% | Plan not stated | SEC |
| Oct 10, 2016 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 14,897 | $1.2M | 0.5% | Plan not stated | SEC |
| Sep 1, 2016 | L | Director | Form 4 sale | 130 | $5k | 4.2% | Plan not stated | SEC |
| Jun 1, 2016 | L | Director | Form 4 sale | 203 | $8k | 6.3% | Plan not stated | SEC |
| Apr 4, 2016 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 10,000 | $718k | 0.3% | Plan not stated | SEC |
| Mar 1, 2016 | L | Director | Form 4 sale | 1,500 | $55k | 33.3% | Unusual | SEC |
| Dec 1, 2015 | L | Director | Form 4 sale | 1,500 | $57k | 33.3% | Unusual | SEC |
| Oct 2, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 27,415 | $1.5M | 0.8% | Plan not stated | SEC |
| Aug 10, 2015 | L | Director | Form 4 sale | 1,500 | $58k | 33.3% | Unusual | SEC |
| Jun 18, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 10,000 | $526k | 2.1% | Plan not stated | SEC |
| Jun 16, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 6,000 | $312k | 0.2% | Plan not stated | SEC |
| Jun 12, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 23,000 | $1.2M | 0.7% | Plan not stated | SEC |
| May 19, 2015 | L | Director | Form 4 sale | 1,500 | $62k | 33.3% | Unusual | SEC |
| Mar 20, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 9,000 | $420k | 0.3% | Plan not stated | SEC |
| Mar 18, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 15,679 | $715k | 0.5% | Plan not stated | SEC |
| Feb 17, 2015 | L | Director | Form 4 sale | 1,500 | $63k | 33.3% | Unusual | SEC |
| Jan 6, 2015 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 30,000 | $1.3M | 0.9% | Plan not stated | SEC |
| Nov 12, 2014 | L | Director | Form 4 sale | 1,500 | $65k | 33.3% | Unusual | SEC |
| Oct 14, 2014 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 30,000 | $1.2M | 0.9% | Plan not stated | SEC |
| May 28, 2014 | L | Director | Form 4 sale | 1,500 | $65k | 33.3% | Unusual | SEC |
| Mar 3, 2014 | L | Director | Form 4 sale | 1,200 | $52k | 28.6% | Unusual | SEC |
| Sep 30, 2013 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 50,000 | $1.5M | 1.4% | Plan not stated | SEC |
| Jul 30, 2013 | L | Director | Form 4 sale | 2,400 | $110k | 44.4% | Unusual | SEC |
| Dec 28, 2012 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 24,589 | $716k | 1.0% | Plan not stated | SEC |
| Dec 11, 2012 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 74,840 | $2.2M | 2.8% | Unusual | SEC |
| Jun 13, 2012 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 8,200 | $209k | 0.3% | Plan not stated | SEC |
| Jun 8, 2012 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 11,000 | $279k | 0.4% | Plan not stated | SEC |
| Apr 18, 2011 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 30,000 | $812k | 1.7% | Plan not stated | SEC |
| Apr 6, 2011 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 3,000 | $81k | 4.6% | Plan not stated | SEC |
| Oct 20, 2008 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 24,500 | $240k | 1.3% | Plan not stated | SEC |
| Jan 7, 2005 | CANTEL MEDICAL CORP | Chairman | Form 4 sale | 8,975 | $312k | 0.8% | Plan not stated | SEC |